Dr. Bryon Gentile

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is rated as a Distinguished provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Tomas Neilan is a Cardiologist in Boston,, Massachusetts. Dr. Neilan is rated as a Distinguished provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. His top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Thymectomy, and Heart Transplant.

Raymond Russell is a Cardiologist in Providence, Rhode Island. Dr. Russell is rated as an Advanced provider by MediFind in the treatment of Doxorubicin-Induced Cardiomyopathy. His top areas of expertise are Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, Heart Attack, Coronary Heart Disease, and Pacemaker Implantation.